EQT has sold Spain-based Igenomix – a reproductive medicine and rare diseases diagnostics business – to listed Swedish market peer Vitrolife in a €1.25bn trade sale that will see EQT acquire a minority stake in Vitrolife.
Fund has made four platform investments and backs European digital and technology-based companies
Toni Gillespie joins as chief of talent, while Elisabetta Ricci joins as chief of staff
GP backed the business – then called Ryds Bilglas – via Nordic Capital VIII in 2018
Auction of the Italian producer of natural flavours and ingredients is expected to launch in early 2022